Stryker Corporation
HealthcareNYSE:SYK · New York Stock Exchange
+$8.18 today
Vol 1.65M · Avg 2.49M
Income Statement
Follow revenue through to earnings
Review sales, margins, expenses, and profit trends to see what is actually driving reported earnings over time.
Earnings Waterfall
Revenue to Net Income
Key Ratios
Analysis
$25.3B of revenue converted into $3.3B of net income for the selected period. Gross margin is 63.6% and net margin is 13.3%, showing how much revenue survives after costs and taxes. EPS is $8.64, tying the income statement back to per-share earnings.
Income Statement
Annual data · 5 periods
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $25.1B +11.2% | $22.6B +10.2% | $20.5B +11.1% | $18.4B +7.8% | $17.1B | $809.6M | $921.6M | $731.2M |
| Cost of Revenue | $9.1B +5.1% | $8.6B +7.6% | $8.0B +8.0% | $7.4B +15.8% | $6.4B | $725.6M | $804.0M | $882.4M |
| Gross Profit | $16.1B +14.9% | $14.0B +11.9% | $12.5B +13.2% | $11.0B +3.1% | $10.7B | $8.9B | $7.6B | $6.2B |
| Gross Margin | 64.0% +2.1pp | 61.9% +0.9pp | 61.0% +1.1pp | 59.8% -2.8pp | 62.6% | 9.8% | 28.9% | 38.3% |
| Research & Development | $1.6B +11.9% | $1.4B +9.4% | $1.3B +5.1% | $1.2B +8.6% | $1.1B | $983.2M | $1.3B | $490.4M |
| Selling, General & Admin | $8.7B +15.3% | $7.5B +8.5% | $6.9B +13.9% | $6.1B +4.5% | $5.8B | $620.6M | $923.0M | -$1.5B |
| Operating Expenses | $11.2B +25.3% | $8.9B +8.6% | $8.2B +12.4% | $7.3B +5.2% | $6.9B | $5.3B | $7.0B | $8.7B |
| Depreciation & Amortization | $1.2B +13.6% | $1.1B +2.1% | $1.0B +3.0% | $998.0M +0.8% | $990.0M | $374.2M | $1.2B | $631.8M |
| EBITDA | $6.3B +27.9% | $4.9B -2.4% | $5.1B +25.9% | $4.0B +11.4% | $3.6B | -$15.2B | $6.8B | $9.3B |
| EBITDA Margin | 25.1% +3.3pp | 21.9% -2.8pp | 24.7% +2.9pp | 21.8% +0.7pp | 21.1% | 5.6% | 46.3% | 42.0% |
| Operating Income | $4.9B -3.4% | $5.1B +18.2% | $4.3B +14.6% | $3.7B -0.8% | $3.8B | $12.3B | $14.0B | -$15.7B |
| Operating Margin | 19.5% -2.9pp | 22.4% +1.5pp | 20.9% +0.6pp | 20.2% -1.8pp | 22.0% | 16.6% | 24.1% | 22.0% |
| Interest Income | $121.0M -12.9% | $139.0M +85.3% | $75.0M -20.2% | $94.0M +38.2% | $68.0M | -$1.5B | -$1.6B | $405.0M |
| Interest Expense | $607.0M +53.3% | $396.0M +11.2% | $356.0M +5.6% | $337.0M +0.0% | $337.0M | $1.1B | $1.0B | $1.2B |
| Other Income / Expenses | -$375.0M +76.1% | -$1.6B -158.1% | -$608.0M +42.2% | -$1.1B +29.1% | -$1.5B | -$1.5B | $1.4B | $1.2B |
| Income Before Tax | $4.5B +29.3% | $3.5B -4.9% | $3.7B +36.9% | $2.7B +17.6% | $2.3B | $3.3B | $4.9B | $3.6B |
| Pre-Tax Margin | 18.0% +2.5pp | 15.5% -2.5pp | 17.9% +3.4pp | 14.5% +1.2pp | 13.3% | 20.8% | 18.7% | 26.2% |
| Income Tax Expense | $1.3B +154.1% | $499.0M -1.8% | $508.0M +56.3% | $325.0M +13.2% | $287.0M | $1.3B | -$1.6B | $745.2M |
| Net Income | $3.2B +8.5% | $3.0B -5.4% | $3.2B +34.2% | $2.4B +18.3% | $2.0B | $4.9B | $4.8B | $4.7B |
| Net Margin | 12.9% -0.3pp | 13.2% -2.2pp | 15.4% +2.7pp | 12.8% +1.1pp | 11.7% | 12.4% | 17.5% | 22.5% |
| EPS (Basic) | $8 +8.0% | $8 -5.8% | $8 +33.9% | $6 +17.8% | $5 | $400.8M | $703.2M | $1.3B |
| EPS (Diluted) | $8 +8.2% | $8 -5.9% | $8 +33.7% | $6 +18.2% | $5 | $766.2M | $609.4M | $452.6M |
| Weighted Avg Shares | $382.2M +0.3% | $381.0M +0.4% | $379.6M +0.4% | $378.2M +0.3% | $377.0M | $757.8M | $925.8M | $1.1B |
| Weighted Avg Shares (Diluted) | $382.2M -0.9% | $385.6M +0.5% | $383.7M +0.4% | $382.2M -0.0% | $382.3M | $1.2B | $924.4M | $678.0M |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
Amgen Inc.
NASDAQ:AMGN
$190.83B
Gilead Sciences, Inc.
NASDAQ:GILD
$155.38B
Pfizer Inc.
NYSE:PFE
$149.18B
Danaher Corporation
NYSE:DHR
$127.33B
Vertex Pharmaceuticals Incorporated
NASDAQ:VRTX
$112.63B
Sanofi
NASDAQ:SNY
$106.45B
Medtronic plc
NYSE:MDT
$103.11B
McKesson Corporation
NYSE:MCK
$94.81B
HCA Healthcare, Inc.
NYSE:HCA
$85.73B
Boston Scientific Corporation
NYSE:BSX
$69.81B
SEC Filings
Recent regulatory filings
No filings found.
How much revenue does SYK generate?
Stryker Corporation (SYK) reported $25.12B of revenue in fiscal 2025.
Is SYK profitable?
Stryker Corporation (SYK) reported $3.25B of net income, with a net margin of 12.9%.
Explore More
Continue the stock analysis
Jump to another research area for this company.